pleriksafor onkogen 20 mg/ml otopina za injekciju
onkogen kft., becsi ut 77-79, budimpešta, mađarska - pleriksafor - otopina za injekciju - urbroj: 1 ml otopine sadrži 20 mg pleriksafora jedna bočica sadrži 24 mg pleriksafora u 1,2 ml otopine
siofor 1000 1000 mg/1 tableta film tableta
berlin chemie / menarini bh d.o.o. sarajevo - metformin - film tableta - 1000 mg/1 tableta - 1 film tableta sadrži: 1000 mg metformina
siofor 1000 1000 mg/1 tableta film tableta
berlin chemie / menarini bh d.o.o. sarajevo - metformin - film tableta - 1000 mg/1 tableta - 1 film tableta sadrži: 1000 mg metformina
fordex 1000mg film tableta
bosnalijek d.d. predstavniŠtvo crna gora - metformin - film tableta - 1000mg
siofor 500 500mg film tableta
"berlin-chemie/menarini montenegro" d.o.o.- podgorica - metformin - film tableta - 500mg
siofor 850 850mg film tableta
"berlin-chemie/menarini montenegro" d.o.o.- podgorica - metformin - film tableta - 850mg
siofor 1000 1000mg film tableta
"berlin-chemie/menarini montenegro" d.o.o.- podgorica - metformin - film tableta - 1000mg
metformin replek farm 850 mg/1 tableta film tableta
unifarm d.o.o. lukavac - metformin - film tableta - 850 mg/1 tableta - 1 filmtableta sadrži: 850 mg metforminhidrohlorida
forxiga
astrazeneca ab - dapagliflozin propandiol monohidrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - lijekovi koji se koriste u dijabetesu - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. osim drugih lijekova za liječenje šećerne bolesti tipa 2 . for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 i 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. trostruki kombinovanu terapiju) kao dodatak prehrani i vježbe kod pacijenata, nedovoljno kontroliranim o njihovo maksimalno переносимой doze метформина i sulfonilurejom. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.